Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Anamorelin is a drug that mimics the function of ghrelin in the human body, which can increase appetite and increase muscle mass, and is used to improve weight and appetite problem···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：164
Koselugo is a carefully developed small molecule MEK inhibitor (also known as a Schengen-activated antagonist) with a focus on precisely targeted therapies for specific tumor types···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：217
Koselugo is a class of finely designed small molecule MEK blockers (also known as mitogen activation inhibitors), and its core therapeutic strategy is targeted therapy for specific···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：212
Koselugo is a precisely targeted small molecule MEK inhibitor with a therapeutic focus on targeted therapies targeting specific tumor types, especially in the treatment of neurofib···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：235
Koselugo is a class of precision small molecule MEK inhibitors (also regarded as schizogenic activation antagonists), and its core efficacy focuses on targeted therapy for specific···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：187
Koselugo is a small molecule MEK inhibitor (figogen activation inhibitor) that is mainly used for the treatment of certain types of tumors, especially in the treatment of neurofibr···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：188
Anamorelin is a drug for cancer cachexia that increases a patient's appetite and weight by mimicking the effects of ghrelin. This drug can significantly improve the nutritional···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：237
As a selective ghrelin receptor agonist, anamolin is approved in Japan for improving the health of cancer cachexia patients. By promoting appetite and gaining weight, it has a posi···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：179
Through its unique pharmacological effects, Anamoreline is effective in helping cancer patients overcome weight loss and loss of appetite. Drugs have shown therapeutic potential in···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：152
Anamorelin helps cancer patients with dyscrasia restore the body's energy supply by stimulating appetite and increasing growth hormone secretion. It is currently the only widel···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：197
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by various cancers such as non-small cell lung cancer. The drug has performed well in multiple clinical tria···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：234
Anamorelin is a novel ghrelin receptor agonist specifically designed for the treatment of cancer cachexia. It provides vital support to patients with advanced cancer by increasing ···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：302
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3172024-09-07
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：132025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：232025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：272025-27-11
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended：3062025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended：2712025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended：3522024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended：2492024-24-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
